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Abstract 
BACKGROUND: Depression is prevalent during antenatal and postnatal stages of pregnancy. The effect of 
depression can be seen in complications during and after pregnancy, fetal growth retardation, abortions and 
preterm births. The literature abounds on postpartum depression (PD) while few studies are on antepartum 
depression (AD). 
AIM: The systematic review aims to compute the prevalence of AD from published articles. 
MATERIAL AND METHODS: The published articles (26) used in this review were obtained from the search of the 
search keywords “Depressive conditions in pregnancy AND trimesters”. All the articles were considered 
irrespective of language and their citation status as of the time of the query. Only articles that presented the 
prevalence mean and sample size were included. Articles on questionnaires filled by nonpregnant women and 
men were excluded. Articles that presented the prevalence of depression for the postpartum period only were 
excluded but were included if they addressed depression at both postpartum and trimester(s) of pregnancy. P-
value of less than or equal to 0.05 was considered significant. 
RESULTS: Analysis of the 26 articles showed that 4,303 subjects tested positive for depression in a sample of 
28,248 pregnant mothers, giving the prevalence rate as 15%. Confounding was removed, and the sample size 
was adjusted to be 25,771 and 4,223 were screened to have depressive symptoms, thereby giving a new 
prevalence rate as 16.4%. It was also revealed that AD is most prevalent in the last trimester of pregnancy and 
least in the second trimester. Pregnancy duration and PD are not correlated with AD. This implies that AD can be 
observed in any period of the pregnancy and cannot predict the incidence of PD. 
CONCLUSION: Efforts must be intensified to monitor pregnant women during the third trimester to reduce the 
incidence of maternal depression during pregnancy, thereby reducing the prevalence. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
The onset of pregnancy can temporarily alter 
the hormonal balance in women which predispose 
them to a different form of affective disorders such as 
depression [1]. Depression is one of the medical and 
psychological conditions in pregnancy [2]. Maternal 
depression is often considered to be a predictor of 
increased incidence of preterm births, miscarriages, 
retarded fetal growth which can manifest as low 
birthweight and so on. Depression can occur in the 
first, second and third trimesters of pregnancy and 
can be measured using different scientific 
instruments. Furthermore, antidepressant medications 
[2] and psychotherapeutic interventions [3] are the 
available treatments for depressive disorders in pre-
natal and post-natal stages of pregnancy. However, it 
has been found that the use of antidepressant is 
linked to cardiac malfunctions [4] and affects 
treatment response especially in the cases of severe 
depression [5].  
It appears that most available research done 
on depression is focused on postpartum depression 
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which is prevalent among pregnant women [6], [7]. 
This review is to present evidence of the prevalence 
of depression during trimesters of pregnancy and its 
implications to healthcare management, although, the 
second trimester is the period of intense depression 
which also is subject of debate [8].  
Depression occurs in varying degrees for a 
different form of child delivery such as vaginal 
delivery, Cesarean Section Delivery and assisted 
vaginal delivery [9]. Some psychiatric, physiological 
and socioeconomic variables have been attributed as 
risk factors or predictors of antepartum depression. 
They are listed as: sleep deprivation [10], [11], sexual 
function during pregnancy [12], weak social structure 
[13], lack of support from family and loved ones [14], 
obesity [15], trauma, anxiety and violence [16] and 
unplanned pregnancies [17]. Summary of some 
factors associated with the prevalence of depressive 
symptoms in pregnant women is given in Table 1.  
Table 1: Major Factors Associated with Antepartum Depression 
Authors  Authors  
[18] Socioeconomic problems such as 
financial problems, lack of family 
support and inadequate housing 
contribute to depressive disorders. 
[31] Prevalence of antepartum 
depression in Eastern Europe. 
[19] Negative psychosocial factors 
contribute to depression. 
[32] The link between cognitive 
behaviour and depression 
during pregnancy. 
[20] Psychological factors observed during 
pregnancy can predict postpartum 
depression. 
[33] Depression is associated with 
the economic status of 
pregnant women. 
[21] Depression is associated with poverty. [34] Immigrant pregnant women are 
at high risk of depressive 
disorders. 
[22] Antenatal/ antepartum depression and 
anxiety are prevalent in pregnant 
women. 
[35] Prevalence of anxiety and 
depression in the antepartum 
stage of pregnancy. 
[23] Antepartum depression is prevalent 
among Latinas in the U.S. and 
Mexico. 
[36] Pathophysiology of depression 
[24] Unintended or unplanned pregnancy 
is associated with depression. 
[37] Gestational diabetes is 
positively correlated with 
depression. 
[25] Psychiatric disorders are associated 
with depression. 
[38] Depression is associated with 
the previous history of nausea, 
abortions and poor housing 
conditions. 
[26] Lower socioeconomic status is 
associated with depression. 
[39] Lack of social support in the 
workplace is associated with 
depression. 
[27] Antepartum depression is a predictor 
of perceived disability in women. 
[40] Co-morbidity of antepartum 
depression with other mental 
illness were studied. 
[28] The reliability of the self-reported 
version of the Inventory of Depressive 
Symptomatology (IDS-SR), as a tool 
for measuring depression, was 
investigated. 
[41] Smoking cessation is 
associated with antepartum 
depression. 
[29] The prevalence of depressive 
symptoms in teenage pregnancies 
was investigated. 
[42] Some psychosocial risks 
associated with depression 
were stated. 
[30] Supplementary selenium intake is 
associated with depression. 
[43] Prevalence of antepartum and 
postpartum depression in 
Portuguese women. 
 
 
 
Material and Methods 
 
Data Collection 
A search of the articles was done on the 
Scopus database using the search keywords; 
“Depressive conditions in pregnancy AND trimesters”. 
Four hundred and seventy (470) articles were initially 
obtained from the keyword “Depressive conditions in 
pregnancy”, and the search results were narrowed 
down to one hundred and thirteen (113) articles using 
the keyword “trimesters”. All the articles were 
considered irrespective of language and their citation 
status as of the time of query which is 14
th
 February 
2019.  
 
Inclusion and Exclusion Criteria 
Only articles that presented the prevalence 
mean and sample size were included. Articles on 
questionnaires filled by nonpregnant women and men 
were excluded. Articles that presented prevalence of 
depression for postpartum period only were excluded 
but are included if they addressed depression at both 
postpartum and trimester(s) of pregnancy. A total of 
twenty-six (26) articles [18], [19], [20], [21], [22], [23], 
[24], [25], [26], [27], [28], [29], [30], [31], [32], [33], 
[34], [35], [36], [37], [38], [39], [40], [41], [42], [43] 
were selected and included in the review. The main 
findings are presented in Table 1. 
 
Survey of the Data Collection Instruments 
Scaled questionnaires are the widely form of 
data collection for investigating both antepartum and 
postpartum depression. The questionnaires are 
designed to identify depressive symptoms which are 
assessed using the final score. The questionnaires 
are of different variants and are designed to achieve 
the aim of a screening tool for depression. Prominent 
among them is the Edinburgh Postnatal Depressive 
Scale (EPDS). The list of all the sixteen (16) tools 
used in the 26 articles for data collection is presented 
in Table 2.  
Table 2: Data Collection Tools Used in the Screening of 
depression in Pregnant Women 
Instrument Acronym  Acronym 
Beck Depression 
Inventory 
BDI Center for Epidemiological Studies 
Depression Scale 
CES-D 
Beck Depression 
Inventory II 
BDI-II Alcohol Use Disorder and Associated 
Disabilities Interview Schedule - DSM-
IV version. 
AUDADIS 
Questionnaire Q Patient Health Questionnaire 
depression module 
PHQ-9 
The anticipation of 
Childbirth Questionnaire  
ACQ General Anxiety Scale GAD-7 
Edinburgh Depression 
Scale 
EDS Inventory of Depressive 
Symptomatology 
IDS-SR 
Edinburgh Postnatal 
Depression Scale 
EPDS International Neuropsychiatric 
Interview 
INI 
Schedule for Clinical 
Assessment in Neuro-
psychiatry 
SCAN National Institute of Child Health and 
Human Development Fetal Growth 
Studies-Singleton cohort (2009–
2013), 
NICH 
Hospital Anxiety and 
Depression Scale 
HADS Postpartum Depression Predictors 
Inventory-Revised 
PDPI-R 
 
 
Statistical Analysis 
The prevalence of antepartum depression 
was presented using exploratory and inferential 
statistics. Correlation, regression and logistic 
regression were applied to obtain the result. Similar 
Okagbue et al. Systematic Review of Prevalence of Antepartum Depression During the Trimesters of Pregnancy 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2019 May 15; 7(9):1555-1560.                                                                                                                                                  1557 
 
applications of the tools can be found in [44], [45], 
[46], [47], [48], [49], [50].  
 
 
Results 
 
The data obtained from the 26 articles are 
presented in Table 3. The data is the summary of the 
trimesters, postpartum considered, the instrument 
used in data collection (questionnaire types), sample 
sizes, varying mean prevalence and the subjects 
observed to be depressed (assessed using the 
questionnaires). The trimester can be first, second or 
third or the depression may be observed throughout 
the antenatal period. Postpartum depression may be 
studied alongside antepartum depression. Often, the 
later is used to predict the former.  
Table 3: The Summary of the Data Collected from the 26 
Articles  
Author Trimester Postpartum Data Inst Sample 
size 
Prevalence +ve 
depression 
[18] 3 No BDI 98 47% 46 
[18] 3 No BDI 46 20% 9 
[19] All No Q 396 41% 162 
[20] 2 Yes ACQ & EPDS 197 12.4% 24 
[21] 3 Yes SCAN 791 20.2% 160 
[22] All Yes HADS 357 54% 193 
[23] All No CES-D 108 32.4% 35 
[23] All No CES-D 117 36.8% 43 
[24] All Yes BDI-II 215 10.2% 22 
[25] All Yes AUDADIS 14549 12.4% 1804 
[26] 3 Yes EPDS 600 24.3% 146 
[27] 3 Yes PHQ-9 & GAD-7 1030 29% 299 
[28] 3 NO IDS-SR 543 11% 60 
[29] All NO INI 828 17.8% 147 
[30] All Yes EPDS 475 12% 57 
[31] All No BDI 503 19.9% 100 
[32] All Yes EPDS 74 28.4% 21 
[33] 2 No EPDS 74 86.5% 64 
[34] 3 No EPDS 228 37% 84 
[35] 3 No CES-D 207 73.5% 152 
[36] 1 Yes PHQ-9 944 27.6% 260 
[37] 1 Yes NICH 2477 3.78% 94 
[37] 2 Yes NICH 2477 3.23% 80 
[38] 3 Yes PHQ-9 225 31.1% 70 
[39] 3 No EPDS 153 13.7% 21 
[40] All Yes EDS 99 13% 13 
[41] All Yes BDI 253 41.5% 105 
[42] All Yes EPDS 44 22.3% 10 
[43] 2 Yes PDPI-R 140 15.4% 22 
 
 
Estimation of Prevalence of Antepartum 
Depression 
The prevalence of depression is computed 
using the data in Table 3. The prevalence in 
percentage is the ratio of the numbers of those 
screened to be depressed using the various 
questionnaires to the total number of subjects 
available for the respective researches.   The 
prevalence of antepartum depression is:   
4303
% Prevalence  0.1523 100 15%
28248
     
 
Out of 28,248 pregnant women screened for 
depression, 4303 were diagnosed to have depression.  
The result is further refined to remove 
confounding contributed by [37]. The new prevalence 
of antepartum depression is:  
4223
% Prevalence  0.1639 100 16.4%
25771
     
 
Generally, out of 25,771 pregnant women 
screened for depressive symptoms, 4223 (16.4%) 
were found to be positive for depression.  
 
Distribution of Antepartum Prevalence 
across the Trimesters  
The prevalence of antepartum depression 
was computed to determine how depression is 
observed in the 3 trimesters and when it is observed 
throughout the gestation period.  
Table 4: Distribution of Antepartum Depression across the 
Pregnancy Trimesters 
Number of articles Trimester Sample size +ve depression % prevalence 
2 1 3421 354 10.35 
4 2 2888 190 6.58 
10 3 3921 1047 26.70 
13 All 18018 2712 15.05 
 
It can be seen from Table 4, that AD is most 
prevalent in the last trimester of pregnancy and least 
in the second trimester. The prevalent throughout the 
gestation is quite close to the mean prevalent 
obtained without confounding. Confounding is not an 
issue here because the authors considered more than 
a trimester. This increased the number of articles to 
29 as shown in Table 4.  
  
Ante-Postpartum Depression 
The prevalence is obtained when postpartum 
depression is studied along with the antepartum. It is 
always important to show if the antepartum 
depression is a predictor of postpartum depression. 
This is presented in Table 5.  
Table 5: Antepartum and Postpartum Depress across the 
trimesters  
Trimester Postpartum Sample size +ve depression 
1 No 0 0 
1 Yes 3421 354 
2 No 74 64 
2 Yes 2617 102 
3 No 1177 326 
3 Yes 2646 675 
All No 1952 487 
All Yes 16066 2225 
 
The prevalence for each case was not 
computed because of the small sample sizes. 
However, it can be seen from Table 5 that antepartum 
depression is usually studied with postpartum 
depression.  
 
Review Article 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
1558                                                                                                                                                                                              https://www.id-press.eu/mjms/index 
 
Distribution of Prevalence as Measured 
with Various Data Instruments   
Sixteen (16) different questionnaires were 
used as an instrument of data collection by the 
articles. The instruments were divided into three 
(EDPS, BDI and others) and their corresponding AD 
prevalence was obtained. The frequencies of the use 
of EDPS, BDI and other questionnaires in the 26 
articles are 8, 5 and 16 respectively, assuming that 
confounding remains constant. This is shown in Table 
6, and it can be seen that the use of other data 
instruments shown in Table 2 presents lower AD 
prevalence (14.2%) than the duo of EDPS (23.8%) 
and BDI (25.3%). 
Table 6: Prevalence, as Measured with Various Data 
Instruments, Grouped into Three 
Data instrument N Sample size +ve depression % prevalence 
EDPS 8 1747 416 23.8 
BDI 5 1115 282 25.3 
OTHERS 16 25386 3605 14.2 
 
Correlation between Pregnancy Duration 
and the Antepartum Depression 
The correlation between the pregnancy 
duration (trimesters) and AD was obtained using three 
(3) correlation coefficients. The result is presented in 
Table 7, where it is observed that there is no 
correlation between pregnancy duration and 
antepartum depression at 0.05 level of significance.  
Table 7: Correlation coefficient for the Relationship between 
Pregnancy Duration and AD 
Correlation Coefficient Value P value 
Pearson (Product moment) 0.126 0.515 
Spearman’s rank -0.065 0.739 
Kendall’s tau -0.054 0.715 
 
Correlation between Data Instrument and 
the Antepartum Depression 
The correlation between the data collection 
instrument used in the articles and AD was obtained 
using three (3) correlation coefficients, and the result 
is presented in Table 8. It is observed that there is a 
significant intermediate positive correlation between 
data collection instrument and antepartum depression 
at 0.05 level of significance. However, Pearson 
correlation showed a weak positive correlation and no 
association.  
Table 8: Correlation coefficient for the Relationship between 
Data Instrument and AD 
Correlation Coefficient Value P value 
Pearson (Product moment) 0.248 0.195 
Spearman’s rank 0.492 0.007 
Kendall’s tau 0.389 0.010 
 
Correlation between Postpartum and the 
Antepartum Depression 
There was no correlation at 0.05 level of 
significance between the Postpartum and AD. This is 
presented in Table 9 where it can be seen that the 
near-zero value of the three (3) correlation coefficients 
connotes no association.  
Table 9: Correlation coefficient for the Relationship between 
PD and AD  
Correlation Coefficient Value P value 
Pearson (Product moment) 0.187 0.332 
Spearman’s rank 0.096 0.619 
Kendall’s tau 0.080 0.611 
 
 
 
Discussion 
 
The review has systematically identified 26 
articles that investigated the prevalence of antepartum 
depression. Nonpregnant women were excluded. 
Furthermore, sixteen [16] data collection tools used in 
the screening of depression in pregnant mothers were 
identified. These are variants of questionnaires 
constructed to detect depressive symptoms in 
pregnant women.  
Analysis of the 26 articles showed that 4,303 
subjects tested positive for depression in a sample of 
28,248 pregnant mothers, giving the prevalence rate 
as 15%. Confounding was removed, and the sample 
size was adjusted to be 25,771 and 4,223 were 
screened to have depressive symptoms, thereby 
giving a new prevalence rate as 16.4%. The prevalent 
rate is higher than 10% obtained by [2].  
It was also revealed that AD is most prevalent 
in the last trimester of pregnancy and least in the 
second trimester. The prevalent throughout the 
gestation is quite close to the mean prevalent 
obtained without confounding. This may be connected 
with the advanced hormonal changes in the perinatal 
stages and anxiety over the delivery process, 
psychosocial, socioeconomic and psychological 
variables. Efforts must be intensified to monitor 
pregnant women at the third semester to reduce the 
trio of depression, anxiety and suicide ideation. 
Moreover, the intervention which can come in a 
different form can prove decisive in ensuring 
unhindered fetal development and prevention of 
postpartum depression.  
Pregnancy duration is not correlated with 
antepartum depression at 0.05 level of significance. 
This implies that a pattern that showed how the two 
variables are related cannot be obtained. Technically, 
AD can occur at any trimesters or throughout the 
pregnancy. Depression can occur at any duration of 
pregnancy based on the unfortunate combinations of 
some psychosocial, socioeconomic and psychological 
factors.  
Finally, the presence of AD is not correlated 
with PD, which means that depression can occur at 
any trimesters of pregnancy and also in the 
postpartum period. The prevalence is not domiciled in 
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any period but can manifest in the three (3) trimesters, 
throughout the antepartum and postpartum periods.  
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